Birmingham, West Midlands -- (SBWIRE) -- 01/29/2014 -- Value Penny Stocks issues special report on Peregrine Pharmaceuticals (NASDAQ:PPHM), Polycom Inc (NASDAQ:PLCM), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Delcath Systems, Inc. (NASDAQ:DCTH).
Peregrine Pharmaceuticals (NASDAQ:PPHM) ended its recent business day with the gain of 1.19% and closed at the price of $1.70 after opening at $1.69. The stock traded during its last trading session with the total volume of 2.28 million shares, as compared to its average volume of 4.19 million shares. Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of monoclonal antibodies focused on the treatment and diagnosis of cancer.
Will PPHM Continue To Move Higher? Find Out Here
Polycom Inc (NASDAQ:PLCM) remained among the day advancers and traded with volume of 2.27 million shares in the last session, as compared to average volume of 2.34 million shares. In comparison with 52 week range of $9.00 - $12.25, it faced lowest price of $11.89 during the last trading session whereas its day highest price was $12.24. The company’s total market capitalization is $1.64 billion, along with 135.00 million shares outstanding. Polycom, Inc. provides standards-based unified communications and collaboration (UC&C) solutions for voice and video collaboration.
Why Should Investors Buy PLCM After The Recent Gain? Just Go Here and Find Out
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) showed 2.21 million shares in volume during the last trading session, while the average trading volume remained 2.86 million shares. The stock kicked off its trading session at $3.40 and closed at $3.55 after mounting 5.65%. Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States.
For How Long AVNR will Fight for Profitability? Read This Trend Analysis report
Delcath Systems, Inc. (NASDAQ:DCTH) stock traded during its last trading session with the total traded volume of 2.21 million shares versus its average volume of 6.05 million shares. The company opened its trade at the price of $0.32 and its closing price was $0.330 after gaining 6.28% for the day. Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on the field of oncology.
Why Should Investors Buy DCTH After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)